Mark Saad

(Mr. Mark Saad)

Currently holds a position at Axsome Therapeutics Inc

Positions

Position Company Period
Independent Director Axsome Therapeutics Inc Dec. 1, 2014 -
Chief Financial Officer Plus Therapeutics Inc June 1, 2004 - Aug. 11, 2014
Mark Saad's trades of Axsome Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-11 2024-09-11
PS Planned sale
11,016 -52.4%
91.31
USD 1,005,871 		11,016 -52.4% 91.31 USD 1,005,871
2021-11-19 2021-11-17
B Purchase
100 +inf%
34.40
USD 3,440 		100 +inf% 34.40 USD 3,440
2021-11-19 2021-11-17
B Purchase
100 +inf%
34.45
USD 3,445 		100 +inf% 34.45 USD 3,445
2021-11-19 2021-11-17
B Purchase
100 +inf%
34.40
USD 3,440 		100 +inf% 34.40 USD 3,440
2021-11-19 2021-11-17
B Purchase
3,000 +42.8%
34.53
USD 103,597 		3,000 +42.8% 34.53 USD 103,597
2019-05-24 2019-05-23
B Purchase
3,500 +99.9%
22.33
USD 78,155 		3,500 +99.9% 22.33 USD 78,155
// ... existing code ... // ... rest of the file ...